La Jolla Pharmaceutical Company - Company Profile
Powered by 
All the sales intelligence you need on La Jolla Pharmaceutical Company in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how La Jolla Pharmaceutical Company fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with La Jolla Pharmaceutical Company.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on La Jolla Pharmaceutical Company patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| TW202214219A | Application | Methods for treating hypotension | A61K2300/00; A61K31/137; A61K38/085; A61K38/22; A61K47/26; A61K9/0019; A61P9/00; A61P9/02 | April 16, 2022 |
| TWI754225B | Grant | Methods for treating hypotension | A61K2300/00; A61K31/137; A61K38/085; A61K38/22; A61K47/26; A61K9/0019; A61P9/00; A61P9/02 | February 01, 2022 |
| WO2021022258A1 | Application | Tetracycline compounds for the treatment of hematological cancers | A61P37/00; A61K31/40; A61K31/635 | February 04, 2021 |
| WO2020252333A1 | Application | Methods for administering angiotensin ii by monitoring renin levels | A61K38/085; A61K9/0019; A61K38/095; A61K31/401; A61K31/472; A61K31/404; A61K31/403; A61K31/675; A61K31/55; A61P9/02 | December 17, 2020 |
| TW202038927A | Application | Methods for treating hypotension | A61K2300/00; A61K31/137; A61K38/085; A61K38/22; A61K47/26; A61K9/0019; A61P9/00; A61P9/02 | November 01, 2020 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer